Belgian College of Neuropsychopharmacology and Biological Psychiatry 

Sebastiaan Engelborghs

Bibliography

1. Full-length papers in PubMed-cited international peer-reviewed journals (h-index: 31 on July 2, 2012)


1.    Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg W, Engelborghs S, De Deyn PP. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimers Dement, in press.
2.    Azermai M, Engelborghs S, Elseviers MM, Vander Stichele RH, Van der Mussele S, Debruyne H, Van Bortel L, Petrovic M. The effect of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study. Aging Ment Health, in press.
3.    Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Incidence of upper limb oedema in patients with acute hemiparetic stroke. Disability and Rehabilitation, in press.
4.    Engelborghs S, Le Bastard N. The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease (invited current opinion article). Mol Diagn Ther. 2012 Jun 1;16(3):135-41. doi: 10.2165/11634170-000000000-00000. PubMed PMID: 22646065.
5.    Van der Mussele S, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults. Int J Geriatr Psychiatry. 2012 Apr 30. doi: 10.1002/gps.3820. [Epub ahead of print] PubMed PMID: 22549770.
6.    Boon P, Engelborghs S, Hauman H, Jansen A, Lagae L, Legros B, Ossemann M, Sadzot B, Smets K, Urbain E, van Rijckevorsel K. Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update. Acta Neurol Belg. 2012 Jun;112(2):119-31. Epub 2012 Apr 28. PubMed PMID: 22544726; PubMed Central PMCID: PMC3375006.
7.    Naudé PJ, Nyakas C, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, Luiten PG, De Deyn PP, den Boer JA, Eisel UL. Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 2012 Jul;26(7):2811-23. Epub 2012 Mar 21. PubMed PMID: 22441986.
8.    Le Bastard N, Engelborghs S. The value of CSF biomarkers for the differential dementia diagnosis (invited review). Neurodegen Dis Manage. 2012;2(2):211-9.
9.    Verstraeten A, Wauters E, Crosiers D, Meeus B, Corsmit E, Elinck E, Mattheijssens M, Peeters K, Cras P, Pickut B, Vandenberghe R, Engelborghs S, De Deyn PP, Van Broeckhoven C, Theuns J. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiol Aging. 2012 Aug;33(8):1844.e11-3. Epub 2012 Feb 14. PubMed PMID: 22336192.
10.    Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, Le Bastard N, Pasquier F, Vermeulen S, Van Dongen J, Mattheijssens M, Peeters K, Mayeux R, St George-Hyslop P, Amouyel P, De Deyn PP, Sleegers K, Van Broeckhoven C. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener. 2012 Jan 16;7:3. PubMed PMID: 22248099; PubMed Central PMCID: PMC3296573.
11.    Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs  S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, De Bleecker J, Maes G, Bäumer V, Dillen L, Joris G, Cuijt I, Corsmit E, Elinck E, Van Dongen J, Vermeulen S, Van den Broeck M, Vaerenberg C, Mattheijssens M, Peeters K, Robberecht W, Cras P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of  the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012 Jan;11(1):54-65. Epub 2011 Dec 7.  Erratum in: Lancet Neurol. 2012 Feb;11(2):125. PubMed PMID: 22154785.
12.    Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, Peeters K, Corsmit E, Elinck E, Pickut B, Vandenberghe R, Cras P, De Deyn PP, Van Broeckhoven C, Theuns J. DLB and PDD: a role for mutations in dementia and Parkinson disease genes? Neurobiol Aging. 2012 Mar;33(3):629.e5-629.e18. Epub 2011 Nov 26. PubMed PMID: 22118943.
13.    Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement. 2012 Jan;8(1):65-73. Epub 2011 Nov 2. PubMed PMID: 22047631.
14.    Van Langenhove T, van der Zee J, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Mattheijssens M, Peeters K, Nuytten D, Cras P, De Deyn PP, De Jonghe P, Cruts M, Van Broeckhoven C. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging. 2012 May;33(5):1004.e17-20. Epub 2011 Oct 27. PubMed PMID: 22035589.
15.    Engelborghs S. [Searched for and found: non-demented patients with Alzheimer's disease]. Tijdschr Psychiatr. 2011;53(9):654-6. Dutch. PubMed PMID: 21898323.
16.    Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis  JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol. 2011 Oct;10(10):898-908. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870. PubMed PMID: 21885347; PubMed Central PMCID: PMC3208320.
17.    Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers  R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P; PSP Genetics Study Group, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Müller U, Schellenberg GD. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19;43(7):699-705. doi: 10.1038/ng.859. PubMed PMID: 21685912; PubMed Central PMCID: PMC3125476.
18.    Vermeiren Y, Le Bastard N, Clark CM, Engelborghs S, De Deyn PP. Serum glutamine synthetase has no value as a diagnostic biomarker for Alzheimer's disease. Neurochem Res. 2011 Oct;36(10):1858-62. Epub 2011 May 20. PubMed PMID: 21597934.
19.    Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido  MJ, Engelborghs S, De Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fiévet N,  Brouwers N, Bettens K, Arosio B, Coto E, Del Zompo M, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini  E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P,  Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues JF, Kamboh MI, Van Broeckhoven C, Lambert JC, Amouyel P, Campion D. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011 Sep;16(9):903-7. doi: 10.1038/mp.2011.52. Epub 2011 May 10. PubMed PMID: 21556001; PubMed Central PMCID: PMC3162068.
20.    De Smet HJ, Engelborghs S, Paquier PF, De Deyn PP, Mariën P. Cerebellar-induced apraxic agraphia: a review and three new cases. Brain Cogn. 2011 Aug;76(3):424-34. Epub 2011 Apr 19. Review. PubMed PMID: 21507544.
21.    Claes S, Myint AM, Domschke K, Del-Favero J, Entrich K, Engelborghs S, De Deyn P, Mueller N, Baune B, Rothermundt M. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes. Psychiatry Res. 2011 Aug 15;188(3):355-60. Epub 2011 Apr 13. PubMed PMID: 21492941.
22.    Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL 3rd, Brooks WS,  Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Lladó A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IR, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VM, Trojanowski JQ, Van Deerlin VM. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011 Apr;68(4):488-97. PubMed PMID: 21482928; PubMed Central PMCID: PMC3160280.
23.    Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown  KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J,  Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton  AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; Alzheimer's Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon  O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA,  Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May;43(5):429-35. Epub 2011  Apr 3. PubMed PMID: 21460840; PubMed Central PMCID: PMC3084173.
24.    Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Is activity loss predictive for development of upper limb oedema after stroke? J Rehabil Med. 2011 Apr;43(5):398-403. PubMed PMID: 21412674.
25.    Brouwers N, Cauwenberghe CV, Engelborghs S, Lambert JC, Bettens K, Bastard NL, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, Deyn PP, Cruts M, Amouyel P, Sleegers K, Broeckhoven CV. Alzheimer risk associated with a  copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry. 2012 Feb;17(2):223-33. doi: 10.1038/mp.2011.24. Epub 2011 Mar 15. PubMed PMID: 21403675; PubMed Central PMCID: PMC3265835.
26.    van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Joris G, Brys J, Mattheijssens M, Peeters K, Cras P, De Deyn PP, Cruts M, Van Broeckhoven C. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain. 2011 Mar;134(Pt 3):808-15. PubMed PMID: 21354975; PubMed Central PMCID: PMC3044834.
27.    Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Incidence of upper limb oedema in patients with acute hemiparetic stroke. Disabil Rehabil. 2011;33(19-20):1791-6. Epub 2011 Jan 16. PubMed PMID: 21235426.
28.    De Witte L, Brouns R, Kavadias D, Engelborghs S, De Deyn PP, Mariën P. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex. 2011 Mar;47(3):273-319. Epub 2010 Sep 26. Review. PubMed PMID: 21111408.
29.    Aries MJ, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, De Deyn PP, Engelborghs S. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. Int J Geriatr Psychiatry. 2010  Nov;25(11):1186-95. PubMed PMID: 20957694.
30.    Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, D'Haenens E, Verte D, Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer's disease and elderly depression: A cross-sectional pilot study. Aging Ment Health. 2011 Jan;15(1):113-21. PubMed PMID: 20924811.
31.    Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fiévet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alpérovitch A, Ruiz A, Kamboh MI, Amouyel P. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis. 2010;22(1):247-55. PubMed PMID: 20847397; PubMed Central PMCID: PMC2964875.
32.    Vanhooren V, Dewaele S, Libert C, Engelborghs S, De Deyn PP, Toussaint O, Debacq-Chainiaux F, Poulain M, Glupczynski Y, Franceschi C, Jaspers K, van der Pluijm I, Hoeijmakers J, Chen CC. Serum N-glycan profile shift during human ageing. Exp Gerontol. 2010 Oct;45(10):738-43. Epub 2010 Aug 27. PubMed PMID: 20801208.
33.    De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol. 2010 Aug;67(8):949-56. PubMed PMID: 20697045; PubMed Central PMCID: PMC2963067.
34.    Brouwers N, Bettens K, Gijselinck I, Engelborghs S, Pickut BA, Van Miegroet H, Montoya AG, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Contribution of TARDBP to Alzheimer's disease genetic etiology. J Alzheimers Dis. 2010;21(2):423-30. PubMed PMID: 20555136.
35.    Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE; FReJA Consortium, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL 3rd, Weiner MF, Geser F, Van Deerlin VM, Trojanowski JQ, Miller BL, Seeley WW, van der Zee J, Kumar-Singh S, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bigio EH, Deng HX, Halliday GM, Kril JJ, Munoz DG, Mann DM, Pickering-Brown SM, Doodeman V, Adamson G, Ghazi-Noori S, Fisher EM, Holton JL, Revesz T, Rossor MN, Collinge J, Mead S, Isaacs AM. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010 Jul;120(1):33-41. Epub 2010 May 20. PubMed PMID: 20490813; PubMed Central PMCID: PMC2887939.
36.    Gijselinck I, Engelborghs S, Maes G, Cuijt I, Peeters K, Mattheijssens M, Joris G, Cras P, Martin JJ, De Deyn PP, Kumar-Singh S, Van Broeckhoven C, Cruts M. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2010 May;67(5):606-16. PubMed PMID: 20457961.
37.    Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP. Altered serum glycomics in Alzheimer disease: a potential blood biomarker? Rejuvenation Res. 2010 Aug;13(4):439-44. PubMed PMID: 20426627.
38.    Le Bastard N, Leurs J, Blomme W, De Deyn PP, Engelborghs S. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. J Alzheimers Dis. 2010;21(1):291-301. PubMed PMID: 20421698.
39.    Bettens K, Brouwers N, Van Miegroet H, Gil A, Engelborghs S, De Deyn PP, Vandenberghe R, Van Broeckhoven C, Sleegers K. Follow-up study of susceptibility  loci for Alzheimer's disease and onset age identified by genome-wide association. J Alzheimers Dis. 2010;19(4):1169-75. PubMed PMID: 20308783.
40.    Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Peeters K, Mattheijssens M,  Elinck E, Corsmit E, De Deyn PP, Van Broeckhoven C, Theuns J. Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36. J Alzheimers Dis. 2010;20(1):197-205. PubMed PMID: 20164589.
41.    Gebruers N, Vanroy C, Truijen S, Engelborghs S, De Deyn PP. Monitoring of physical activity after stroke: a systematic review of accelerometry-based measures. Arch Phys Med Rehabil. 2010 Feb;91(2):288-97. Review. PubMed PMID: 20159136.
42.    Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, Van den Broeck M, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Van Broeckhoven C. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010 Feb 2;74(5):366-71. PubMed PMID: 20124201.
43.    Krüger R, Sharma M, Riess O, Gasser T, Van Broeckhoven C, Theuns J, Aasly J,  Annesi G, Bentivoglio AR, Brice A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Klein C, Lambert JC, Lesage S, Lin JJ, Lynch T, Mellick GD, de Nigris F, Opala G, Prigione A, Quattrone A, Ross OA, Satake W, Silburn PA, Tan EK, Toda T, Tomiyama H, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM; Genetic Epidemiology of Parkinson's disease consortium. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging. 2011 Mar;32(3):548.e9-18. Epub 2009 Dec 24. PubMed PMID: 20036034.
44.    De Smet HJ, Baillieux H, Wackenier P, De Praeter M, Engelborghs S, Paquier PF, De Deyn PP, Mariën P. Long-term cognitive deficits following posterior fossa  tumor resection: a neuropsychological and functional neuroimaging follow-up study. Neuropsychology. 2009 Nov;23(6):694-704. PubMed PMID: 19899828.
45.    Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O,  Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O; European Alzheimer's Disease Initiative Investigators, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanché H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alpérovitch A, Lathrop M, Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009 Oct;41(10):1094-9. Epub 2009 Sep 6. PubMed PMID: 19734903.
46.    Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009 Oct;41(10):1088-93. Epub 2009 Sep 6. Erratum in: Nat Genet. 2009 Oct;41(10):1156. PubMed PMID: 19734902; PubMed Central PMCID: PMC2845877.
47.    van der Zee J, Pirici D, Van Langenhove T, Engelborghs S, Vandenberghe R, Hoffmann M, Pusswald G, Van den Broeck M, Peeters K, Mattheijssens M, Martin JJ,  De Deyn PP, Cruts M, Haubenberger D, Kumar-Singh S, Zimprich A, Van Broeckhoven C. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology. 2009 Aug 25;73(8):626-32. PubMed PMID: 19704082.
48.    Le Bastard N, Aerts L, Leurs J, Blomme W, De Deyn PP, Engelborghs S. No correlation between time-linked plasma and CSF Abeta levels. Neurochem Int. 2009 Dec;55(8):820-5. Epub 2009 Aug 18. PubMed PMID: 19695299.
49.    Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Neurochem Int. 2009 Sep;55(4):214-8. Epub 2009 Mar 5. PubMed PMID: 19524111.
50.    Evangelou E, Maraganore DM, Annesi G, Brighina L, Brice A, Elbaz A, Ferrarese C, Hadjigeorgiou GM, Krueger R, Lambert JC, Lesage S, Markopoulou K, Mellick GD, Meeus B, Pedersen NL, Quattrone A, Van Broeckhoven C, Sharma M, Silburn PA, Tan EK, Wirdefeldt K, Ioannidis JP; Genetic Epidemiology of Parkinson's Disease (GEOPD) Consortium. Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):220-8. PubMed PMID: 19475631.
51.    Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum Mutat. 2009 Aug;30(8):1207-13. PubMed PMID: 19462468.
52.    Rollinson S, Rohrer JD, van der Zee J, Sleegers K, Mead S, Engelborghs S, Collinge J, De Deyn PP, Mann DM, Van Broeckhoven C, Pickering-Brown SM. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging. 2011 Apr;32(4):754-5. Epub 2009 May 14. PubMed PMID: 19446372.
53.    Nuytemans K, Meeus B, Crosiers D, Brouwers N, Goossens D, Engelborghs S, Pals P, Pickut B, Van den Broeck M, Corsmit E, Cras P, De Deyn PP, Del-Favero J, Van Broeckhoven C, Theuns J. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population. Hum Mutat. 2009 Jul;30(7):1054-61. PubMed PMID: 19405094.
54.    Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Pals P, Pickut B, Peeters K, Mattheijssens M, Corsmit E, Cras P, De Deyn PP, Theuns J, Van Broeckhoven C. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population. Neurobiol Aging. 2011 Feb;32(2):308-12. Epub 2009 Mar 24. PubMed PMID: 19321232.
55.    Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J, Peeters K, Mattheijssens M, Cruts M, Vandenberghe R, De Deyn PP, Robberecht W, Van Broeckhoven C. Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol. 2009 May;65(5):603-9. PubMed PMID: 19288468.
56.    Dierckx E, Engelborghs S, De Raedt R, Van Buggenhout M, De Deyn PP, Verté D, Ponjaert-Kristoffersen I. Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment. Int J Geriatr Psychiatry. 2009 Oct;24(10):1094-100. PubMed PMID: 19280679.
57.    Vandervliet EJ, Verhoeven J, Engelborghs S, De Deyn PP, Parizel PM, Mariën P. FMRI findings in an aphasic patient with reversed cerebral dominance for language. Acta Neurol Belg. 2008 Dec;108(4):161-6. PubMed PMID: 19239047.
58.    Boon P, Engelborghs S, Hauman H, Jansen A, Lagae L, Legros B, Ossemann M, Sadzot B, Urbain E, van Rijckevorsel K. Recommendations for the treatment of epilepsies in general practice in Belgium. Acta Neurol Belg. 2008 Dec;108(4):118-30. PubMed PMID: 19239040.
59.    Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat. 2009 Apr;30(4):E570-4. PubMed PMID: 19191332.
60.    Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S. Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiol Aging. 2010 Nov;31(11):1867-76. Epub 2009 Jan 15. PubMed PMID: 19150153.
61.    Debruyne H, Van Buggenhout M, Le Bastard N, Aries M, Audenaert K, De Deyn PP, Engelborghs S. Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment? Int J Geriatr Psychiatry. 2009 Jun;24(6):556-62. PubMed PMID: 19132643.
62.    Mariën P, Verhoeven J, Wackenier P, Engelborghs S, De Deyn PP. Foreign accent syndrome as a developmental motor speech disorder. Cortex. 2009 Jul-Aug;45(7):870-8. Epub 2008 Nov 21. PubMed PMID: 19121521.
63.    De Witte L, Verhoeven J, Engelborghs S, De Deyn PP, Mariën P. Crossed aphasia and visuo-spatial neglect following a right thalamic stroke: a case study and review of the literature. Behav Neurol. 2008;19(4):177-94. Review. PubMed PMID: 19096142.
64.    Dierckx E, Engelborghs S, De Raedt R, Van Buggenhout M, De Deyn PP, Verleye G, Verte D, Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? J Geriatr Psychiatry Neurol. 2008 Dec;21(4):242-9. PubMed PMID: 19017781.
65.    Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Hum Mutat. 2009 Feb;30(2):E338-44. PubMed PMID: 18853460.
66.    Nuytemans K, Pals P, Sleegers K, Engelborghs S, Corsmit E, Peeters K, Pickut  B, Mattheijssens M, Cras P, De Deyn PP, Theuns J, Van Broeckhoven C. Progranulin variability has no major role in Parkinson disease genetic etiology. Neurology. 2008 Oct 7;71(15):1147-51. PubMed PMID: 18838661.
67.    Gebruers N, Truijen S, Engelborghs S, Nagels G, Brouns R, De Deyn PP. Actigraphic measurement of motor deficits in acute ischemic stroke. Cerebrovasc Dis. 2008;26(5):533-40. Epub 2008 Oct 6. PubMed PMID: 18836264.
68.    Aries MJ, Debruyne H, Engelborghs S, Le Bastard N, Somers N, Gorissen D, Pickut BA, De Deyn PP. Reversal of head drop after discontinuation of olanzapine in a DLB patient. Mov Disord. 2008 Sep 15;23(12):1760-2. PubMed PMID: 18661562.
69.    De Witte L, Engelborghs S, Verhoeven J, De Deyn PP, Mariën P. Disrupted auto-activation, dysexecutive and confabulating syndrome following bilateral thalamic and right putaminal stroke. Behav Neurol. 2008;19(3):145-51. PubMed PMID: 18641434.
70.    Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I, van der Zee J, Pickut BA, Van den Broeck M, Mattheijssens M, Peeters K, Schymkowitz J, Rousseau F, Martin JJ, Cruts M, De Deyn PP, Van Broeckhoven C. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology. 2008 Aug 26;71(9):656-64. Epub 2008 Jun 18. PubMed PMID: 18565828.
71.    Bettens K, Brouwers N, Engelborghs S, De Deyn PP, Van Broeckhoven C, Sleegers K. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum Mutat. 2008 May;29(5):769-70. PubMed PMID: 18407551.
72.    Bogaerts V, Nuytemans K, Reumers J, Pals P, Engelborghs S, Pickut B, Corsmit E, Peeters K, Schymkowitz J, De Deyn PP, Cras P, Rousseau F, Theuns J, Van Broeckhoven C. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum Mutat. 2008 Jun;29(6):832-40. PubMed PMID: 18401856.
73.    Mariën P, Baillieux H, De Smet HJ, Engelborghs S, Wilssens I, Paquier P, De Deyn PP. Cognitive, linguistic and affective disturbances following a right superior cerebellar artery infarction: a case study. Cortex. 2009 Apr;45(4):527-36. Epub 2008 Mar 2. PubMed PMID: 18396269.
74.    Mariën P, Brouns R, Engelborghs S, Wackenier P, Verhoeven J, Ceulemans B, De  Deyn PP. Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome. Cortex. 2008 Jan;44(1):54-67. Epub 2007 Nov 17. PubMed PMID: 18387531.
75.    Bettens K, Brouwers N, Engelborghs S, De Pooter T, De Deyn PP, Sleegers K, Van Broeckhoven C. DNMBP is genetically associated with Alzheimer dementia in the Belgian population. Neurobiol Aging. 2009 Dec;30(12):2000-9. Epub 2008 Mar 24. PubMed PMID: 18359537.
76.    Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, De Deyn PP, Engelborghs S, Pickut B, Uitti RJ, Foroud T, Nichols WC, Hagenah J, Klein C, Samii A, Zabetian CP, Bonifati V, Van Broeckhoven C, Farrer MJ, Wszolek ZK. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology. 2008 Apr 15;70(16 Pt 2):1456-60. Epub 2008 Mar 12. PubMed PMID: 18337586.
77.    Nuytemans K, Rademakers R, Theuns J, Pals P, Engelborghs S, Pickut B, de Pooter T, Peeters K, Mattheijssens M, Van den Broeck M, Cras P, De Deyn PP, van Broeckhoven C. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. Eur J Hum Genet. 2008 Apr;16(4):471-9. Epub 2008 Jan 16. PubMed PMID: 18197194.
78.    Gijselinck I, van der Zee J, Engelborghs S, Goossens D, Peeters K, Mattheijssens M, Corsmit E, Del-Favero J, De Deyn PP, Van Broeckhoven C, Cruts M. Progranulin locus deletion in frontotemporal dementia. Hum Mutat. 2008 Jan;29(1):53-8. PubMed PMID: 18157829.
79.    Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Mariën P, Somers N, Nagels G, Pickut BA, De Deyn PP. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem Int. 2008 May;52(6):1052-60. Epub 2007 Nov 4. PubMed PMID: 18093695.
80.    Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin JJ, Vandenberghe R, Sciot R, Dermaut B, Goossens D, van der Zee J, De Pooter T, Del-Favero J, Santens P, De Jonghe P, De Deyn PP, Van Broeckhoven C, Cruts M. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging. 2009 Aug;30(8):1329-31. Epub 2008 Jan 10. PubMed PMID: 18068872.
81.    van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, De Pooter T, Peeters K, Santens P, De Deyn PP, Fisher EM, Collinge J, Isaacs AM, Van Broeckhoven C. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet. 2008 Jan 15;17(2):313-22. Epub 2007 Oct 22. PubMed PMID: 17956895.
82.    Brouwers N, Nuytemans K, van der Zee J, Gijselinck I, Engelborghs S, Theuns J, Kumar-Singh S, Pickut BA, Pals P, Dermaut B, Bogaerts V, De Pooter T, Serneels S, Van den Broeck M, Cuijt I, Mattheijssens M, Peeters K, Sciot R, Martin JJ, Cras P, Santens P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol. 2007 Oct;64(10):1436-46. PubMed PMID: 17923627.
83.    Nagels G, D'hooghe MB, Kos D, Engelborghs S, De Deyn PP. Within-session practice effect on paced auditory serial addition test in multiple sclerosis. Mult Scler. 2008 Jan;14(1):106-11. Epub 2007 Sep 24. PubMed PMID: 17893110.
84.    Le Bastard N, Van Buggenhout M, De Leenheir E, Martin JJ, De Deyn PP, Engelborghs S. LOW specificity limits the use of the cerebrospinal fluid AB1-42/P-TAU181P ratio to discriminate alzheimer's disease from vascular dementia. J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):923-4; author reply 924-5. PubMed PMID: 17702886.
85.    Bogaerts V, Engelborghs S, Kumar-Singh S, Goossens D, Pickut B, van der Zee J, Sleegers K, Peeters K, Martin JJ, Del-Favero J, Gasser T, Dickson DW, Wszolek ZK, De Deyn PP, Theuns J, Van Broeckhoven C. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain. 2007 Sep;130(Pt 9):2277-91. Epub 2007 Aug 6. PubMed PMID: 17681982.
86.    Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De Leenheir E, Martin JJ, Vanmechelen E, Van Broeckhoven C, De Deyn PP. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Brain. 2007 Sep;130(Pt 9):2320-6. Epub 2007 Jun 22. PubMed PMID: 17586559.
87.    Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin JJ, Vanmechelen E, De Deyn PP. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging. 2008 Aug;29(8):1143-59. Epub 2007 Apr 10. PubMed PMID: 17428581.
88.    Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, Kapaki E, Tsolaki M, Daniilidou M, Molyva D, Paraskevas GP, Thal DR, Barcikowska M, Kuznicki J, Lannfelt L, Van Broeckhoven C, Nitsch RM, Hock C, Papassotiropoulos A. Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 2007 Aug;8(3):179-88. Epub 2007 Mar 27. PubMed PMID: 17387528.
89.    van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, De Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, De Deyn PP, Rousseau F, Brice A, Van Broeckhoven C. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat. 2007 Apr;28(4):416. PubMed PMID: 17345602.
90.    Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging. 2007Jan;27(1):17-22. PubMed PMID: 17204033.
91.    Nagels G*, Engelborghs S*, Vloeberghs E, Lemmens W, Pickut BA, De Deyn PP. Correlation between actigraphy and nurses' observation of activity in dementia. Int J Geriatr Psychiatry. 2007 Jan;22(1):84-6. PubMed PMID: 17171751. (*joint first authors)
92.    Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall. Psychol Med. 2007 May;37(5):747-55. Epub 2006 Dec 13. PubMed PMID: 17164030.
93.    Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I. Mild cognitive impairment: what's in a name? Gerontology. 2007;53(1):28-35. Epub 2006 Sep 20. Review. PubMed PMID: 16988509.
94.    Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, Corsmit E, De Leenheir E, Martin JJ, De Deyn PP, Van Broeckhoven C, Theuns J. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain. 2006 Nov;129(Pt 11):2984-91. Epub 2006 Aug 24. PubMed PMID: 16931535.
95.    Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.Nature. 2006 Aug 24;442(7105):920-4. Epub 2006 Jul 16. PubMed PMID: 16862115.
96.    Engelborghs S, Maertens K, Mariën P, Vloeberghs E, Somers N, Nagels G, De Deyn PP. Behavioural and neuropsychological correlates of frontal lobe features in dementia. Psychol Med. 2006 Aug;36(8):1173-82. Epub 2006 May 15. PubMed PMID: 16700962.
97.    Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, De Pooter T, van Duijn CM, De Deyn PP, Van Broeckhoven C. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet. 2006 Jun;78(6):936-46. Epub 2006 Apr 10. PubMed PMID: 16685645; PubMed Central PMCID: PMC1474091.
98.    Nagels G*, Engelborghs S*, Vloeberghs E, Van Dam D, Pickut BA, De Deyn PP. Actigraphic measurement of agitated behaviour in dementia. Int J Geriatr Psychiatry. 2006 Apr;21(4):388-93. PubMed PMID: 16534768. (*joint first authors)
99.    Verhoeven J, Mariën P, Engelborghs S, D'Haenen H, De Deyn P. A foreign speech accent in a case of conversion disorder. Behav Neurol. 2005;16(4):225-32. PubMed PMID: 16518013.
100.    van der Zee J, Rademakers R, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R, Santens P, Caekebeke J, De Pooter T, Peeters K, Lübke U, Van den Broeck M, Martin JJ, Cruts M, De Deyn PP, Van Broeckhoven C, Dermaut B. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain. 2006 Apr;129(Pt 4):841-52. Epub 2006 Feb 22. PubMed PMID: 16495329.
101.    Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP. Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochem Int. 2006 Mar;48(4):286-95. Epub 2006 Jan 24. PubMed PMID: 16434124.
102.    Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goeman J, Rademakers R, Van den Broeck M, Pickut B, Cruts M, Van Broeckhoven C, De Deyn PP. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiol Aging. 2006 Feb;27(2):285-92. PubMed PMID: 16399213.
103.    Mariën P, Abutalebi J, Engelborghs S, De Deyn PP. Pathophysiology of language switching and mixing in an early bilingual child with subcortical aphasia. Neurocase. 2005 Dec;11(6):385-98. PubMed PMID: 16393752.
104.    Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Mariën P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005 Nov;20(11):1028-37. PubMed PMID: 16250064.
105.    De Witte L, Wilssens I, Engelborghs S, De Deyn PP, Mariën P. Impairment of syntax and lexical semantics in a patient with bilateral paramedian thalamic infarction. Brain Lang. 2006 Jan;96(1):69-77. Epub 2005 Oct 13. PubMed PMID: 16226805.
106.    Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, van Duijn CM, De Deyn PP,  Van Broeckhoven C, Dermaut B. The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years. Neurosci Lett. 2006 Jan 9;392(1-2):72-4. Epub 2005 Oct 6. PubMed PMID: 16214290.
107.    Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, Baker  M, Sleegers K, Crook R, De Pooter T, Bel Kacem S, Adamson J, Van den Bossche D, Van den Broeck M, Gass J, Corsmit E, De Rijk P, Thomas N, Engelborghs S, Heckman M, Litvan I, Crook J, De Deyn PP, Dickson D, Schellenberg GD, Van Broeckhoven C, Hutton ML. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 2005 Nov 1;14(21):3281-92. Epub 2005 Sep 29. PubMed PMID: 16195395.
108.    Mariën P, Verhoeven J, Engelborghs S, Rooker S, Pickut BA, De Deyn PP. A role for the cerebellum in motor speech planning: evidence from foreign accent syndrome. Clin Neurol Neurosurg. 2006 Jul;108(5):518-22. Epub 2005 Aug 1. PubMed PMID: 16055261.
109.    Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP. Regional distribution of biogenic amines, amino acids and cholinergic markers in  the CNS of the C57BL/6 strain. Amino Acids. 2005 Jun;28(4):377-87. Epub 2005 May 17. PubMed PMID: 15889219.
110.    Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochem Int. 2005 Apr;46(5):409-22. Epub 2005 Jan 17. PubMed PMID: 15737439.
111.    De Deyn PP*, Engelborghs S*, Saerens J, Goeman J, Mariën P, Maertens K, Nagels G, Martin JJ, Pickut BA. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease. Int J Geriatr Psychiatry. 2005 Jan;20(1):70-9. PubMed PMID: 15578673. (*joint first authors)
112.    Vloeberghs E, Van Dam D, Engelborghs S, Nagels G, Staufenbiel M, De Deyn PP. Altered circadian locomotor activity in APP23 mice: a model for BPSDdisturbances. Eur J Neurosci. 2004 Nov;20(10):2757-66. PubMed PMID: 15548219.
113.    Engelborghs S, Holmes C, McCulley M, De Deyn PP. 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease. Int J Geriatr Psychiatry. 2004 Nov;19(11):1108-9. PubMed PMID: 15497194.
114.    Brouns R, Crols R, Engelborghs S, De Deyn PP. Pituitary apoplexy presenting as chemical meningitis. Lancet. 2004 Aug 7-13;364(9433):502. PubMed PMID: 15302191.
115.    Engelborghs S, Vloeberghs E, Maertens K, Marescau B, De Deyn PP. Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1080. PubMed PMID: 15201387; PubMed Central PMCID: PMC1739124.
116.    Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J,  Pickut BA, Peeters K, van den Broeck M, Vennekens K, Claes S, Cruts M, Cras P, Martin JJ, Van Broeckhoven C, De Deyn PP. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol. 2004 May;55(5):617-26. PubMed PMID: 15122701.
117.    Engelborghs S, Vloeberghs E, Maertens K, Mariën P, Somers N, Symons A, Clement F, Ketels V, Saerens J, Goeman J, Pickut BA, Vandevivere J, De Deyn PP. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. Int J Geriatr Psychiatry. 2004 Apr;19(4):365-70. PubMed PMID: 15065230.
118.    Engelborghs S, Pickut BA, De Deyn PP. Recurrent transient ischemic attacks in a 15-year-old boy with beta-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis. Acta Neurol Belg. 2003 Jun;103(2):99-102. PubMed PMID: 12892004.
119.    Engelborghs S, Dermaut B, Goeman J, Saerens J, Mariën P, Pickut BA, Van den  Broeck M, Serneels S, Cruts M, Van Broeckhoven C, De Deyn PP. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1148-51. PubMed PMID: 12876259; PubMed Central PMCID: PMC1738626.
120.    Engelborghs S, Marescau B, De Deyn PP. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50. PubMed PMID: 12834252.
121.    Mariën P, Engelborghs S, Vignolo LA, De Deyn PP. The many faces of crossed aphasia in dextrals: report of nine cases and review of the literature. Eur J Neurol. 2001 Nov;8(6):643-58. Review. PubMed PMID: 11784349.
122.    Marien P, Engelborghs S, Fabbro F, De Deyn PP. The lateralized linguistic cerebellum: a review and a new hypothesis. Brain Lang. 2001 Dec;79(3):580-600. Review. PubMed PMID: 11781058.
123.    Marien P, Paquier P, Engelborghs S, De Deyn PP. Acquired crossed aphasia in  dextral children revisited. Brain Lang. 2001 Dec;79(3):426-43. Review. PubMed PMID: 11781052.
124.    Marien P, Engelborghs S, De Deyn PP. Cerebellar neurocognition: a new avenue. Acta Neurol Belg. 2001 Jun;101(2):96-109. Review. PubMed PMID: 11486564.
125.    Buyle M, Engelborghs S, Kunnen J, De Deyn PP. Headache as only symptom in multiple cervical artery dissection. Headache. 2001 May;41(5):509-11. PubMed PMID: 11380650.
126.    Marien P, Pickut BA, Engelborghs S, Martin JJ, De Deyn PP. Phonological agraphia following a focal anterior insulo-opercular infarction. Neuropsychologia. 2001;39(8):845-55. PubMed PMID: 11369407.
127.    Engelborghs S, De Deyn PP. Biological and genetic markers of sporadic Alzheimer's disease. Acta Med Okayama. 2001 Apr;55(2):55-63. Review. PubMed PMID: 11332200.
128.    Marien P, Engelborghs S, Paquier P, De Deyn PP. Anomalous cerebral language  organization: acquired crossed aphasia in a dextral child. Brain Lang. 2001 Feb;76(2):145-57. PubMed PMID: 11254255.

2. Full-length papers in international journals, without PubMed citation
1.    N. Le Bastard, P.P. De Deyn, S. Engelborghs. Cerebrospinal fluid biomarkers for the differential diagnosis of dementia. Current Medical Literature – Neurology 2009, 25: 59-68.
2.    P. Mariën, S. Engelborghs, E. Michiels, P.P. De Deyn. Cognitive and linguistic disturbances in the posterior fossa syndrome in children: a diaschisis phenomenon? Brain and Language 2003, 87: 162.
3.    P. Mariën, S. Engelborghs, R. D’Hooge, P.P. De Deyn. Familial sinistrality in crossed aphasia: a new case and review of the available literature. Aphasiology, 2001, 12 (15): 1143-1168.

3. Papers in national journals
1.    S. Engelborghs. Nieuwe diagnostische criteria voor de ziekte van Alzheimer: van een uitsluitingsdiagnose naar een biomarkerdiagnose. Tijdschrift voor Klinische Psychologie 2012, 42 (1): 9-18.
2.    S. Engelborghs. Biomarkers voor de diagnostiek van de ziekte van Alzheimer. Neuron 2012, 17 (5): 13-17.
3.    S. Engelborghs. Gezocht en gevonden: niet-demente patiënten met een ziekte van Alzheimer. Tijdschrift voor Psychiatrie 2011, 53: 654-656.
4.    A. De Ryck, R. Brouns, M. Geurden, M. Elseviers, P.P. De Deyn, S. Engelborghs. Risicofactoren voor depressie na CVA. Een systematische literatuurstudie. Tijdschrift voor Geneeskunde 2009, 65: 282-290.
5.    S. Engelborghs, P.P. De Deyn. Frontotemporale dementie: hulpmiddelen voor vroegtijdige diagnostiek. Neuron 2008, 13: 241-245.
6.    S. Engelborghs, P.P. De Deyn. Démence fronto-temporale: outils pour un diagnostic précoce. Neurone 2008, 13: 241-245.
7.    S. Engelborghs, P.P. De Deyn. Gedragsobservatie als instrument voor vroegtijdige diagnose van frontotemporale dementie. Patient Care Neuropsychiatrie 2008, 3: 5-8.
8.    S. Engelborghs, P.P. De Deyn. Gedragsobservatie als instrument voor vroegtijdige diagnose van frontotemporale dementie. Tijdschrift voor Neuropsychiatrie en Gedragsneurologie 2008, 7: 216-219.
9.    P.F. Paquier, M. Van Mourik, H. Leheckova, M. Ventura, J. Van Borsel, P. Mariën, S. Engelborghs. The cerebellum and language. Folia Phoniatrica et Logopaedica 2007, 59: 163-164.
10.    E. Dierckx, S. Engelborghs, R. De Raedt, M. Van Buggenhout, P.P. De Deyn, D. Verté, I. Ponjaert-Kristoffersen. Mild cognitive impairment: what’s in a name. Neuron 2007, 12: 283-288.
11.    S. Engelborghs, P.P. De Deyn. Neurochemische en genetische correlaten van gedragsstoornissen en psychische symptomen bij dementie. Patient Care Neuropsychiatrie, 2005, 4: 5-13.
12.    S. Engelborghs. Neurochemische en genetische correlaten van gedragsstoornissen bij dementie. Tijdschrift voor Neurologie en Neurochirurgie, 2004, 105: 298-299.
13.    S. Engelborghs. Meten is weten. Neuropraxis, 2004, 8: 107-111.
14.    S. Engelborghs, P.P. De Deyn. Biologische merkers voor de ziekte van Alzheimer. Patient Care, 2003, 26: 65-70.
15.    S. Engelborghs, P.P. De Deyn. Biologische merkers voor de ziekte van Alzheimer. Patient Care (Nederlandse editie), 2003, 2: 31-35.
16.    S. Engelborghs, P.P. De Deyn. Biologische merkers voor de ziekte van Alzheimer. Patient Care Neuropsychiatrie, 2003, 4: 15-24.
17.    P. Mariën, S. Engelborghs, F. Fabbro, P.P. De Deyn. The lateralized linguistic cerebellum: fact or fallacy? Stem-, Taal- en Spraakpathologie, 2002, 11: 47-57.
18.    P. Mariën, P. Paquier, S. Engelborghs, P.P. De Deyn. Acquired crossed aphasia in dextral children revisited. Afasiologie, 2002, 24: 34-36.
19.    S. Engelborghs, P.P. De Deyn. Biologische en genetische merkers voor de ziekte van Alzheimer. Tijdschrift voor Geneeskunde, 2002, 58: 1533-1541.
20.    P.P. De Deyn, E. Mulleners, S. Engelborghs, B.A. Pickut, J. Goeman. Nieuwe geneesmiddelen voor de behandeling van dementie van het Alzheimer type. Ahead in Neurology, 2001, 4: 26-34.

4. Chapters in books
1.    S. Van der Mussele, S. Engelborghs. Frontal lobe symptoms in mild cognitive impairment and dementia. In: Frontal Lobe: Anatomy, Functions and Injuries. Nova Science Publishers, in press.
2.    S. Engelborghs, P. Mariën, P.P. De Deyn. Frontal lobe dysfunction across diagnostic dementia categories. In: Neuropsychological Research. A Review. P. Mariën, J. Abutalebi (Eds.). Hove & New York: Psychology Press, 2008, pp 491-509.
3.    H. Vanderstichele, G. De Meyer, F. Shapiro, S. Engelborghs, P.P. De Deyn, L. Shaw, J.Q. Trojanowski. Alzheimer’s disease biomarkers: from concept to clinical utility. In: BioMarkers for early diagnosis of Alzheimer’s disease. D. Galimberti, E. Scarpini (Eds.). Nova Science Publishers, 2008, pp 81-122.
4.    S. Engelborghs, L. Desmet, N. Willemarck. Taal in degeneratieve dementiebeelden. In: Afasie (z)onder woorden. E. Robert, P. Mariën (Eds.). Antwerpen/Apeldoorn: Garant, 2006, pp 315-327.
5.    P.P. De Deyn, S. Engelborghs, G. Nagels. The practice of dementia care: Belgium.  In: Standards in Dementia Care. A. Burns (Ed.). Oxon: Taylor and Francis, 2005, pp 111-120.
6.    P. Mariën, P Paquier, S. Engelborghs, P.P. De Deyn. Crossed aphasia in children. In: Neurogenic Language Disorders in Children. F. Fabbro (Ed.). Amsterdam: Elsevier, 2004, pp 147-180.
7.    S. Engelborghs, P.P. De Deyn. Biological markers of Alzheimer’s disease.  In: Memory: Basic concepts, Disorders and Treatment. P.P. De Deyn, E. Thiery, R. D’Hooge (Eds.). Leuven: Acco, 2003, pp 275-290.
8.    S. Engelborghs, P.P. De Deyn. The genetics of Alzheimer’s disease. In: Memory: Basic concepts, Disorders and Treatment. P.P. De Deyn, E. Thiery, R. D’Hooge (Eds.). Leuven: Acco, 2003, pp 291-303.
9.    P.P. De Deyn, B.A. Pickut, S. Engelborghs, R. D’Hooge, J. Goeman. Pharmacological therapy of Alzheimer’s disease. In: Memory: Basic concepts, Disorders and Treatment. P.P. De Deyn, E. Thiery, R. D’Hooge (Eds.). Leuven: Acco, 2003, pp 433-451.
10.    P.P. De Deyn, J. Goeman, J. Saerens, S. Engelborghs, S. Verstraeten, P. Mariën, R. D’Hooge, B.A. Pickut. The concept memory clinic: historical perspective and objectives. In: Memory: Basic concepts, Disorders and Treatment. De Deyn PP, Thiery E, D’Hooge R (Eds.). Leuven: Acco, 2003, pp 33-44.
11.    S. Engelborghs, P.P. De Deyn. Moleculaire biologie van geheugen en dementie: nieuwe inzichten en klinische toepassingen. In: Geheugenstoornissen bij jong en oud: onderzoek en praktijk. E. Thiery, P.P. De Deyn, J. Scheiris (Eds.). Leuven: Acco, 2003, pp 77-99.
12.    P.P. De Deyn, J. Goeman, J. Saerens, S. Engelborghs, S. Verstraeten, P. Mariën, R. D’Hooge, B.A. Pickut. Geheugenklinieken: historisch perspectief en opzet. In: Geheugenstoornissen: revalidatie en psychosociale zorg. J. Scheiris, E. Thiery, P.P. De Deyn, H. Van Hove (Eds.). Leuven: Acco, 2003, pp 15-27.

PrintEmail

BCNBP

UPC KU Leuven, Campus Gasthuisberg,
Herestraat 49,
3000 Leuven

VAT BE 0415.048.548

BECOME A MEMBER